Literature DB >> 17787037

A general goodness-of-fit test for Markov and hidden Markov models.

Andrew C Titman1, Linda D Sharples.   

Abstract

Markov models are a convenient and useful method of estimating transition rates between levels of a categorical response variable, such as a disease stage, which changes over time. In medical applications the response variable is typically observed at irregular intervals. A Pearson-type goodness-of-fit test for such models was proposed by Aguirre-Hernandez and Farewell (Statist. Med. 2002; 21:1899-1911), but this test is not applicable in the common situation where the process includes an absorbing state, such as death, for which the time of entry is known precisely nor when the data include censored state observations. This paper presents a modification to the Pearson-type test to allow for these cases. An extension of the method, to allow for the class of hidden Markov models where the response variable is subject to misclassification error, is given. The method is applied to data on cardiac allograft vasculopathy in post-heart-transplant patients. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 17787037     DOI: 10.1002/sim.3033

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  Computation of the asymptotic null distribution of goodness-of-fit tests for multi-state models.

Authors:  Andrew C Titman
Journal:  Lifetime Data Anal       Date:  2009-11-01       Impact factor: 1.588

2.  A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data.

Authors:  Jane M Lange; Rebecca A Hubbard; Lurdes Y T Inoue; Vladimir N Minin
Journal:  Biometrics       Date:  2014-10-15       Impact factor: 2.571

3.  Drinking and smoking patterns during pregnancy: Development of group-based trajectories in the Safe Passage Study.

Authors:  Kimberly Dukes; Tara Tripp; Marian Willinger; Hein Odendaal; Amy J Elliott; Hannah C Kinney; Fay Robinson; Julie M Petersen; Cheryl Raffo; Dale Hereld; Coen Groenewald; Jyoti Angal; Gary Hankins; Larry Burd; William P Fifer; Michael M Myers; Howard J Hoffman; Lisa Sullivan
Journal:  Alcohol       Date:  2017-06-15       Impact factor: 2.405

4.  Reciprocal Markov Modeling of Feedback Mechanisms Between Emotion and Dietary Choice Using Experience-Sampling Data.

Authors:  Ji Lu; Junhao Pan; Qiang Zhang; Laurette Dubé; Edward H Ip
Journal:  Multivariate Behav Res       Date:  2015       Impact factor: 5.923

5.  Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study--a continuous time Markov chain model with Bayesian approach.

Authors:  Junsheng Ma; Wenyaw Chan; Chu-Lin Tsai; Momiao Xiong; Barbara C Tilley
Journal:  Stat Med       Date:  2015-06-29       Impact factor: 2.373

6.  Fitting and interpreting continuous-time latent Markov models for panel data.

Authors:  Jane M Lange; Vladimir N Minin
Journal:  Stat Med       Date:  2013-06-05       Impact factor: 2.373

7.  Multi-state models for the analysis of time-to-event data.

Authors:  Luís Meira-Machado; Jacobo de Uña-Alvarez; Carmen Cadarso-Suárez; Per K Andersen
Journal:  Stat Methods Med Res       Date:  2008-06-18       Impact factor: 3.021

8.  Estimating stroke-free and total life expectancy in the presence of non-ignorable missing values.

Authors:  Ardo van den Hout; Fiona E Matthews
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2010-04       Impact factor: 2.483

9.  Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.

Authors:  Rebecca M Brotman; Michelle D Shardell; Pawel Gajer; J Kathleen Tracy; Jonathan M Zenilman; Jacques Ravel; Patti E Gravitt
Journal:  J Infect Dis       Date:  2014-06-18       Impact factor: 5.226

10.  State selection in Markov models for panel data with application to psoriatic arthritis.

Authors:  Howard H Z Thom; Christopher H Jackson; Daniel Commenges; Linda D Sharples
Journal:  Stat Med       Date:  2015-03-05       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.